Dr. James Foster, M.D

NPI: 1275590218
Total Payments
$29,307
2024 Payments
$4,790
Companies
65
Transactions
1,068
Medicare Patients
26,609
Medicare Billing
$1.0M

Payment Breakdown by Category

Food & Beverage$14,979 (51.1%)
Other$14,288 (48.8%)
Education$39.49 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $14,979 1,013 51.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $14,288 48 48.8%
Education $39.49 7 0.1%

Top Paying Companies

Company Total Records Latest Year
Allergan, Inc. $8,248 29 $0 (2023)
ABBVIE INC. $7,246 97 $0 (2024)
Novo Nordisk Inc $1,749 138 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,102 33 $0 (2024)
Amgen Inc. $1,048 71 $0 (2024)
PFIZER INC. $939.75 78 $0 (2024)
Lilly USA, LLC $856.15 73 $0 (2024)
Amarin Pharma Inc. $791.69 51 $0 (2022)
Merck Sharp & Dohme LLC $756.00 71 $0 (2024)
GlaxoSmithKline, LLC. $632.04 40 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,790 80 ABBVIE INC. ($3,812)
2023 $5,612 128 ABBVIE INC. ($2,764)
2022 $5,409 152 Allergan, Inc. ($3,064)
2021 $5,747 129 Allergan, Inc. ($4,082)
2020 $1,633 111 Amarin Pharma Inc. ($419.67)
2019 $1,900 141 Novo Nordisk Inc ($236.32)
2018 $2,157 154 Novo Nordisk Inc ($245.23)
2017 $2,058 173 Novo Nordisk Inc ($213.81)

All Payment Transactions

1,068 individual payment records from CMS Open Payments — Page 1 of 43

Date Company Product Nature Form Amount Type
12/09/2024 ABBVIE INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $303.00 General
11/08/2024 ABBVIE INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $187.00 General
10/04/2024 ABBVIE INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $201.00 General
09/16/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $23.59 General
Category: NEUROSCIENCE
09/06/2024 ABBVIE INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $383.00 General
08/28/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $19.66 General
Category: NEUROSCIENCE
08/21/2024 Kiniksa Pharmaceuticals International, plc Arcalyst (Drug) Food and Beverage In-kind items and services $17.07 General
Category: Not Applicable
08/12/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $12.36 General
Category: NEUROSCIENCE
08/07/2024 ABBVIE INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $235.80 General
07/29/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $14.59 General
Category: Obesity
07/25/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $12.00 General
Category: NEUROSCIENCE
07/22/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $14.53 General
Category: Diabetes
07/19/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $23.57 General
Category: NEUROSCIENCE
07/16/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $18.08 General
Category: Diabetes
07/11/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $28.82 General
Category: Cardiovascular and Metabolism
07/11/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $23.99 General
Category: Diabetes Care
07/10/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $21.96 General
Category: Diabetes
07/08/2024 Philips North America LLC (CK6) Holter (Device) Food and Beverage Cash or cash equivalent $19.36 General
Category: Medical Device
07/03/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), GARDASIL 9 Food and Beverage In-kind items and services $15.75 General
Category: VACCINE
07/02/2024 ABBVIE INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $337.25 General
07/02/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $2.53 General
Category: NEUROSCIENCE
06/28/2024 Lilly USA, LLC ZEPBOUND (Drug) Food and Beverage In-kind items and services $12.87 General
Category: Obesity
06/28/2024 Lilly USA, LLC ZEPBOUND (Drug) Food and Beverage In-kind items and services $0.68 General
Category: Obesity
06/28/2024 Lilly USA, LLC ZEPBOUND (Drug) Food and Beverage In-kind items and services $0.44 General
Category: Obesity
06/27/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $19.19 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 55 6,656 9,980 $535,140 $265,999
2022 59 6,586 9,834 $543,175 $266,243
2021 58 6,985 10,076 $521,716 $264,217
2020 59 6,382 9,861 $490,970 $227,173
Total Patients
26,609
Total Services
39,751
Medicare Billing
$1.0M
Procedure Codes
231

All Medicare Procedures & Services

231 procedure records from CMS Medicare Utilization — Page 1 of 10

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 420 420 $66,360 $54,138 81.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 486 651 $104,160 $54,024 51.9%
J0897 Injection, denosumab, 1 mg Office 2023 16 1,500 $37,500 $27,193 72.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 276 378 $41,580 $22,316 53.7%
80061 Blood test, lipids (cholesterol and triglycerides) Office 2023 541 804 $32,160 $10,502 32.7%
36415 Insertion of needle into vein for collection of blood sample Office 2023 616 1,098 $12,370 $9,190 74.3%
80053 Blood test, comprehensive group of blood chemicals Office 2023 545 791 $23,730 $8,149 34.3%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 29 29 $9,675 $8,043 83.1%
90662 Influenza vaccine split virus, preservative free Office 2023 96 96 $8,692 $6,892 79.3%
84443 Blood test, thyroid stimulating hormone (tsh) Office 2023 277 323 $16,150 $5,289 32.7%
82306 Vitamin d-3 level Office 2023 159 179 $15,573 $5,141 33.0%
99495 Transitional care management services for problem of at least moderate complexity Office 2023 29 32 $10,304 $4,967 48.2%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 27 27 $6,750 $4,456 66.0%
83036 Hemoglobin a1c level Office 2023 289 456 $12,768 $4,326 33.9%
93880 Ultrasound of both sides of head and neck blood flow Office 2023 39 39 $17,940 $4,235 23.6%
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test Office 2023 518 662 $13,240 $4,180 31.6%
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous Office 2023 209 209 $9,614 $3,697 38.5%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 93 93 $6,324 $3,448 54.5%
G0008 Administration of influenza virus vaccine Office 2023 107 107 $4,240 $3,223 76.0%
87428 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza Office 2023 52 54 $6,750 $2,507 37.1%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 263 265 $21,730 $2,340 10.8%
G0103 Prostate cancer screening; prostate specific antigen test (psa) Office 2023 115 115 $5,970 $2,176 36.4%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Office 2023 19 19 $9,500 $1,598 16.8%
82607 Cyanocobalamin (vitamin b-12) level Office 2023 76 84 $3,780 $1,242 32.8%
G0009 Administration of pneumococcal vaccine Office 2023 32 32 $1,130 $953.55 84.4%

About Dr. James Foster, M.D

Dr. James Foster, M.D is a Family Medicine healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275590218.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Foster, M.D has received a total of $29,307 in payments from pharmaceutical and medical device companies, with $4,790 received in 2024. These payments were reported across 1,068 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($14,979).

As a Medicare-enrolled provider, Foster has provided services to 26,609 Medicare beneficiaries, totaling 39,751 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 231 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Richmond, VA
  • Active Since 04/26/2006
  • Last Updated 09/20/2011
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1275590218

Products in Payments

  • FARXIGA (Drug) $1,010
  • Vascepa (Drug) $791.69
  • Ozempic (Drug) $786.99
  • UBRELVY (Drug) $654.80
  • XIFAXAN (Drug) $480.48
  • NURTEC ODT (Drug) $417.70
  • JARDIANCE (Drug) $386.31
  • JANUVIA (Drug) $372.50
  • XARELTO (Drug) $369.58
  • QULIPTA (Drug) $346.84
  • TRULICITY (Drug) $328.96
  • EVENITY (Biological) $319.86
  • TRINTELLIX (Drug) $313.69
  • ELIQUIS (Drug) $278.47
  • Rybelsus (Drug) $265.41
  • Aimovig (Biological) $248.17
  • ENTRESTO (Drug) $244.95
  • TRELEGY ELLIPTA (Drug) $223.72
  • Victoza (Drug) $223.27
  • NEXLETOL (Drug) $223.13

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Richmond